Literature DB >> 21862981

Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis.

James H Lewis.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21862981     DOI： 10.1038/nrgastro.2011.140

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.

Authors:  Ayako Suzuki; Elizabeth M Brunt; David E Kleiner; Rosa Miquel; Thomas C Smyrk; Raul J Andrade; M Isabel Lucena; Agustin Castiella; Keith Lindor; Einar Björnsson
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

Review 2.  The two faces of hepatitis E virus.

Authors:  Eyasu H Teshale; Dale J Hu; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

3.  Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.

Authors:  C Benichou; G Danan; A Flahault
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

Review 4.  Predicting and preventing acute drug-induced liver injury: what's new in 2010?

Authors:  Gordon Liss; Sushil Rattan; James H Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09       Impact factor: 4.481

5.  Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.

Authors:  Robert J Fontana; Leonard B Seeff; Raúl J Andrade; Einar Björnsson; Christopher P Day; Jose Serrano; Jay H Hoofnagle
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

6.  Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Authors:  Don C Rockey; Leonard B Seeff; James Rochon; James Freston; Naga Chalasani; Maurizio Bonacini; Robert J Fontana; Paul H Hayashi
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

7.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Authors:  G Danan; C Benichou
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

Review 8.  Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.

Authors:  Max A Shapiro; James H Lewis
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

Review 9.  Drug-induced liver injury associated with statins.

Authors:  Mark W Russo; Martin Scobey; Herbert L Bonkovsky
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115

Review 10.  The pathology of drug-induced liver injury.

Authors:  David E Kleiner
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115
  10 in total
  3 in total

1.  Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis.

Authors:  Deepak Amarapurkar; Anjali Amarapurkar
Journal:  J Clin Exp Hepatol       Date:  2015-10-23

2.  Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury.

Authors:  Baolin Niu; Xiaohong Lei; Qingling Xu; Yi Ju; Dongke Xu; Liya Mao; Jing Li; Yufan Zheng; Ning Sun; Xin Zhang; Yimin Mao; Xiaobo Li
Journal:  Cell Biol Toxicol       Date:  2021-08-17       Impact factor: 6.691

3.  Observation of Voriconazole in the Treatment of Liver Failure Complicated With Invasive Pulmonary Fungal Infection Induced by Chinese Patent Medicine in Teenagers: 2 Case Reports.

Authors:  Qian Su; Jinjin Pan; Li Zhang; Lingling Xia; Yufeng Gao; Jiabin Li
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.